Perspective Therapeutics (CATX) Acquisitions (2023)
Perspective Therapeutics recorded quarterly Acquisitions of $2.7 million in Q1 2023.
Perspective Therapeutics' Acquisitions history runs 1 years deep, the most recent figure standing at $2.7 million for Q1 2023.
- In Q1 2023, Acquisitions changed N/A year-over-year to $2.7 million; the TTM figure through Dec 2023 stood at $2.7 million (changed N/A YoY), while the FY2023 annual figure was $2.7 million, changed N/A from the prior year.
- Acquisitions came in at $2.7 million for Q1 2023 at Perspective Therapeutics.
- In the past five years, Acquisitions ranged from a high of $2.7 million in Q1 2023 to a low of $2.7 million in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 523.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -268.10 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.30 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 2.70 Mn |